research feed

Every NR4A2 paper, in plain English

PubMed and the Europe PMC preprint servers are queried daily for NR4A2 and NURR1, back to the earliest records. Each abstract is summarised locally by Qwen3.6 35B and tagged by relevance to a parent of an NR4A2 child. Source links go straight to the paper.

subscribe (Atom feed) · high and medium relevance only

registered clinical trials

Every ClinicalTrials.gov study whose record mentions NR4A2 or NURR1. Most use NURR1 as a Parkinson's biomarker rather than testing anything for this syndrome, so read the conditions line. Studies still open come first. Last checked 2026-09-15.

completed or inactive (4) ›

Low-relevance papers are always set aside, so they are all in the fold-out below rather than the main list.

lower-relevance papers (40) ›
low2009-01-10 · Neuroscience

Expression of layer-specific markers in the adult neocortex of BCNU-Treated rat, a model of cortical dysplasia.

Moroni RF, Inverardi F, Regondi MC, Watakabe A, Yamamori T, Spreafico R, Frassoni C

This study uses a rat model to map how cortical layers become disorganized in brain malformations, identifying specific markers for different neuron types. It does not involve NR4A2, human patients, or potential treatments for this syndrome.

  • The research focuses on general cortical dysplasia, not NR4A2-related syndromes.
  • It uses a rat model treated with BCNU to mimic brain malformations.
  • No human data, genetic findings, or therapeutic insights are provided.
  • The work is basic neuroscience with no direct clinical application.
low2009-01-01 · Drug discovery today. Disease mechanisms

NR4A Orphan Nuclear Receptors in Cardiovascular Biology.

Zhao Y, Bruemmer D

This review describes the general molecular functions of NR4A receptors in cardiovascular biology, focusing on their role in vascular remodeling and atherosclerosis. It does not provide specific information about NR4A2-related neurodevelopmental syndromes or potential treatments for your child.

  • NR4A receptors regulate genes involved in vascular biology and metabolism.
  • The paper focuses on cardiovascular mechanisms, not neurological development.
  • No clinical data or treatment implications for NR4A2 syndrome are presented.
low2009-01-01 · TSitologiia i genetika

[Differentiation of dofaminergic neurons from the human embryonal nerve cells in culture].

Tsymbaliuk VI, Vasyl'ieva IH, Oleksenko NP, Chopyk NH, Tsiubko OI, Halanta OS

Researchers successfully increased the proportion of dopamine-producing neuron precursors in cultured human embryonic nerve tissue by adjusting specific growth conditions. This process confirms that early developmental markers fade while key functional markers rise, demonstrating a method to enrich cell populations for potential future transplantation therapies.

  • Dopaminergic neuron precursor levels increased significantly from 5.6% to 23.5% in experimental cultures.
  • Control samples showed only a modest increase to 8.1%, highlighting the effectiveness of the specific culture conditions.
  • Gene expression analysis confirmed differentiation by tracking the disappearance of early factors and rise of TH.
  • The study demonstrates a protocol for enriching human embryonic tissue with cells suitable for neurotransplantation.
low2009-01-01 · Advances in experimental medicine and biology

Terminal differentiation ofmesodiencephalic dopaminergic neurons: the role of Nurr1 and Pitx3.

Smidt MP, Burbach JP

This paper identifies Nurr1 and Pitx3 as essential transcription factors that drive the final maturation of dopaminergic neurons in the midbrain. It establishes a molecular mechanism for how these proteins work together to ensure proper neuronal development.

  • Nurr1 and Pitx3 are critical for terminal differentiation of mesodiencephalic dopaminergic neurons.
  • The study defines the specific genetic pathway controlling this developmental stage.
  • Findings are based on molecular biology mechanisms without human clinical data.
low2009-01-01 · Cytotherapy

A simple and efficient method for generating Nurr1-positive neuronal stem cells from human wisdom teeth (tNSC) and the potential of tNSC for stroke therapy.

Yang KL, Chen MF, Liao CH, Pang CY, Lin PY

Researchers isolate stem cells from human wisdom teeth and demonstrate that transplanting these cells into rats with stroke-like brain injuries improves neurological recovery. The study confirms that these specific neural stem cells survive transplantation and offer therapeutic potential for stroke in an animal model.

  • Stem cells are successfully isolated from human wisdom teeth using a simple culture method.
  • Transplanted cells survive in the brains of rats with induced stroke injuries.
  • Treated rats show significant neurological recovery compared to untreated controls.
  • The study focuses on stroke therapy, not NR4A2-related syndromes or Parkinson's disease.
low2008-12-27 · Mechanisms of ageing and development

Whole-genome microarray analysis identifies up-regulation of Nr4a nuclear receptors in muscle and liver from diet-restricted rats.

Oita RC, Mazzatti DJ, Lim FL, Powell JR, Merry BJ

Dietary restriction increases Nr4a2 levels in the liver and muscle of rats, suggesting these genes help regulate metabolism rather than brain function. This finding does not provide direct insight into NR4A2-related neurodevelopmental syndromes or potential treatments for affected children.

  • Nr4a2 upregulation occurs in rat liver and muscle during dietary restriction.
  • Brain Nr4a2 levels do not change with dietary restriction in this model.
  • The study links NR4A receptors to metabolic adaptation, not neurological outcomes.
  • This preclinical animal data offers no direct clinical relevance for NR4A2 syndrome.
low2008-12-24 · The Journal of neuroscience : the official journal of the Society for Neuroscience

Lmx1b-controlled isthmic organizer is essential for development of midbrain dopaminergic neurons.

Guo C, Qiu HY, Shi M, Huang Y, Johnson RL, Rubinstein M, Chen SD, Ding YQ

This study shows that the Lmx1b gene is not required inside midbrain dopamine neurons for their survival, but it is essential in surrounding tissue to create the environment that allows these neurons to develop. Restoring this supportive environment rescues dopamine neuron development even when the Lmx1b gene is missing from the neurons themselves. This clarifies that Lmx1b acts as a structural organizer rather than a direct driver of dopamine neuron identity.

  • Lmx1b is not needed inside midbrain dopamine neurons for their differentiation or maintenance.
  • The loss of dopamine neurons in Lmx1b mutants results from disrupted tissue organization, not cell-autonomous failure.
  • Restoring the isthmic organizer environment rescues dopamine neuron development in mutant mice.
  • Lmx1b functions primarily to establish the midbrain-hindbrain boundary signals necessary for neuron formation.
low2008-12-18 · American journal of respiratory cell and molecular biology

Alterations in gene expression in human mesothelial cells correlate with mineral pathogenicity.

Shukla A, MacPherson MB, Hillegass J, Ramos-Nino ME, Alexeeva V, Vacek PM, Bond JP, Pass HI, Steele C, Mossman BT

Asbestos exposure alters gene expression in human mesothelial cells in a dose- and time-dependent way, with the gene ATF3 playing a key role in driving inflammation and growth factor production. The NR4A2 gene was also upregulated by asbestos in ovarian cells, but not in mesothelial cells.

  • Asbestos changes gene expression in human cells
  • ATF3 gene is highly activated by asbestos
  • ATF3 controls inflammatory cytokines and growth factors
  • NR4A2 increased in ovarian cells, not mesothelial cells
  • Nonfibrous particles like talc or TiO2 had minimal effects
low2008-12-13 · Neuroscience

Absence of age-related changes in nigral dopaminergic neurons of Asian Indians: relevance to lower incidence of Parkinson's disease.

Alladi PA, Mahadevan A, Yasha TC, Raju TR, Shankar SK, Muthane U

This study finds that nigral dopaminergic neurons in Asian Indians do not decline with age, unlike in other populations. The researchers observed stable neuron numbers and protein levels across a lifespan from gestation to old age. These findings suggest a biological basis for the lower incidence of Parkinson's disease in this demographic.

  • Nigral dopaminergic neurons remain stable in number and size throughout life in Asian Indians.
  • TH and Nurr1 protein expression levels do not decline with aging in this population.
  • No evidence of neuronal apoptosis was found in the substantia nigra of older subjects.
  • Results contrast with American cohorts where dopaminergic phenotype loss occurs from midlife.
low2008-12-06 · Journal of controlled release : official journal of the Controlled Release Society

Dexamethasone-pDMAEMA polymeric conjugates reduce inflammatory biomarkers in human intestinal epithelial monolayers.

Keely S, Ryan SM, Haddleton DM, Limer A, Mantovani G, Murphy EP, Colgan SP, Brayden DJ

Dexamethasone linked to a mucoadhesive polymer stays active and reduces inflammation in human gut cells, with the conjugate showing strong adhesion and no toxicity, suggesting potential for treating gut inflammation topically.

  • Dexamethasone-polymer conjugates reduce gut inflammation markers
  • Conjugates stick to gut cells and remain non-toxic
  • The drug stays active and is released slowly
  • Potential for topical treatment of intestinal inflammation
  • May help conditions involving gut inflammation
low2008-12-03 · Journal of neurophysiology

Glutamatergic nonpyramidal neurons from neocortical layer VI and their comparison with pyramidal and spiny stellate neurons.

Andjelic S, Gallopin T, Cauli B, Hill EL, Roux L, Badr S, Hu E, Tamás G, Lambolez B

This study characterizes the electrical and structural properties of specific neurons in rat brains, noting that a subset expresses Nurr1 mRNA. It finds no direct link between this genetic marker and how these neurons fire or look.

  • Researchers studied layer VI neurons in rat brain slices using electrophysiology and genetic markers.
  • Most nonpyramidal neurons in this layer are glutamatergic, not GABAergic.
  • A subset of these cells expresses Nurr1 mRNA, a marker for specific projection neurons.
  • Nurr1 expression does not correlate with the neurons' firing patterns or physical shape.
  • The study focuses on basic neuron classification without testing treatments or human outcomes.
low2008-12-01 · Anatomical science international

Visualization of spatiotemporal differentiation of dopaminergic interneurons in adult mouse olfactory bulb using transgenic mice.

Saino-Saito S

This study uses transgenic mice to track how dopamine-producing cells develop in the adult olfactory bulb. It finds that the gene Nurr1 (NR4A2) is active during this process, while other genes are not.

  • Researchers tracked dopamine cell development in adult mouse brains using genetic markers.
  • Nurr1 expression changes alongside dopamine production in these specific brain cells.
  • Other candidate genes did not show similar regulation patterns.
  • The study confirms Nurr1's role in regulating dopamine phenotypes in mice.
low2008-11-13 · Cerebral cortex (New York, N.Y. : 1991)

Novel markers reveal subpopulations of subplate neurons in the murine cerebral cortex.

Hoerder-Suabedissen A, Wang WZ, Lee S, Davies KE, Goffinet AM, Rakić S, Parnavelas J, Reim K, Nicolić M, Paulsen O, Molnár Z

This study identifies nuclear receptor-related 1 (NR4A2) as a specific marker for subplate neurons in the developing mouse brain. It confirms that NR4A2 expression helps distinguish different subpopulations of these early-developing cortical cells.

  • NR4A2 marks subplate neurons in the developing murine cerebral cortex.
  • The study uses mouse models to map NR4A2 expression patterns.
  • No human data or clinical findings are presented in this research.
  • The work focuses on basic developmental biology rather than treatment.
low2008-11-01 · Bulletin of experimental biology and medicine

High level of alpha-synuclein mRNA in peripheral lymphocytes of patients with alcohol dependence syndrome.

Taraskina AE, Filimonov VA, Kozlovskaya YA, Morozova MN, Gaschin DV, Schwarzman AL

People with alcohol dependence have higher levels of alpha-synuclein mRNA in their blood cells, but this does not relate to changes in the NR4A2 gene, which is important for dopamine neuron function.

  • Alpha-synuclein mRNA is elevated in blood cells of alcohol-dependent patients
  • No link found between alpha-synuclein levels and NR4A2 gene expression
  • NR4A2 remains unchanged despite alpha-synuclein increase
  • Findings may reflect broader neurobiological changes in alcohol dependence
low2008-10-27 · PloS one

Wnt5a regulates ventral midbrain morphogenesis and the development of A9-A10 dopaminergic cells in vivo.

Andersson ER, Prakash N, Cajanek L, Minina E, Bryja V, Bryjova L, Yamaguchi TP, Hall AC, Wurst W, Arenas E

Wnt5a signaling guides the development of dopamine-producing neurons by regulating their shape, division, and maturation in the midbrain. Disruption of this pathway causes structural defects in the brain and delays the differentiation of NR4A2-positive precursor cells into functional neurons.

  • Wnt5a activates Rac1 to drive the differentiation of dopaminergic precursors.
  • Mice lacking Wnt5a show delayed maturation of NR4A2+ precursor cells.
  • The absence of Wnt5a causes structural defects in midbrain elongation.
  • Excess precursors remain undifferentiated until later developmental stages.
low2008-10-22 · Molecular endocrinology (Baltimore, Md.)

Inhibition of adipocyte differentiation by Nur77, Nurr1, and Nor1.

Chao LC, Bensinger SJ, Villanueva CJ, Wroblewski K, Tontonoz P

This study shows that NR4A family proteins (Nur77, Nurr1, and Nor1) block the development of fat cells in laboratory mouse cell lines. The researchers identify specific genes and mechanisms by which these proteins inhibit adipocyte differentiation, but they do not investigate brain function or neurological symptoms.

  • NR4A proteins inhibit fat cell formation in mouse preadipocyte cell lines.
  • Nur77 expression increases with inflammatory signals and fasting/refeeding cycles.
  • The inhibition mechanism involves blocking mitotic clonal expansion of cells.
  • Gap-junction protein alpha1 and tolloid-like 1 mediate the anti-adipogenic effects.
  • This effect cannot be reversed by activating PPAR-gamma receptors.
low2008-10-21 · Neurotoxicology and teratology

Repeated developmental exposure to chlorpyrifos and methyl parathion causes persistent alterations in nicotinic acetylcholine subunit mRNA expression with chlorpyrifos altering dopamine metabolite levels.

Eells JB, Brown T

Developmental exposure to the insecticides chlorpyrifos and methyl parathion alters dopamine metabolism and nicotinic acetylcholine receptor expression in rat brains. These changes persist into adulthood, suggesting that early-life pesticide exposure can have long-lasting effects on dopaminergic systems.

  • Chlorpyrifos increases dopamine metabolite levels in adult rats after developmental exposure.
  • Both pesticides alter nicotinic acetylcholine receptor subunit ratios in the substantia nigra.
  • The study uses a rat model, not human participants or NR4A2 genetics.
  • No direct link to NR4A2-related syndrome mechanisms is established.
low2008-10-15 · Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Target identification for CNS diseases by transcriptional profiling.

Altar CA, Vawter MP, Ginsberg SD

This review summarizes gene expression changes in various neuropsychiatric and neurodegenerative disorders to identify potential drug targets. It highlights pathways involving dopamine, glutamate, and neurotrophic factors that are altered in conditions like Parkinson's disease, Alzheimer's disease, and schizophrenia.

  • The paper reviews transcriptional profiling data from human brains, animal models, and cell cultures.
  • It identifies potential drug targets for Alzheimer's, Parkinson's, schizophrenia, bipolar disorder, and depression.
  • Nurr1 is mentioned as a downstream target in Parkinson's disease pathways.
  • The study does not focus on NR4A2-related syndrome or specific treatments for it.
  • Most findings are general mechanisms rather than specific insights for this child's condition.
low2008-10-15 · Molecular human reproduction

Chemically defined sequential culture media for TH+ cell derivation from human embryonic stem cells.

Song T, Chen G, Wang Y, Mao G, Wang Y, Bai H

Researchers developed a reliable method to generate dopamine-producing neurons from human embryonic stem cells that survive and function in Parkinson's disease rat models. These cells release dopamine and reduce motor symptoms when transplanted into rats, demonstrating potential for future cell therapies.

  • Protocol produces over 90% tyrosine hydroxylase-positive cells from human embryonic stem cells.
  • Derived cells release dopamine in response to stimulation in laboratory settings.
  • Transplanted cells survive and reduce motor deficits in Parkinson's disease rat models.
  • Study focuses on cell therapy for Parkinson's, not NR4A2 genetic syndromes.
low2008-10-15 · Journal of cellular biochemistry

Differential transactivation by orphan nuclear receptor NOR1 and its fusion gene product EWS/NOR1: possible involvement of poly(ADP-ribose) polymerase I, PARP-1.

Ohkura N, Nagamura Y, Tsukada T

The fusion protein EWS/NOR1, found in a rare bone cancer, acts differently than the normal NOR1 protein by escaping regulation from a cellular brake called PARP-1. This allows EWS/NOR1 to turn on genes in a way that may drive cancer, while normal NOR1 is kept in check. The difference lies in how these proteins interact with other molecules, especially PARP-1.

  • EWS/NOR1 avoids PARP-1 repression, unlike normal NOR1
  • PARP-1 acts as a brake on NOR1 activity
  • This difference may explain why EWS/NOR1 causes cancer
  • The NR4A family of proteins is regulated by PARP-1 in a gene-specific way
  • EWS/NOR1 gains oncogenic power by escaping normal controls
low2008-10-11 · Biochemical and biophysical research communications

Expression of dopamine-associated genes on conjunctiva stromal-derived human mesenchymal stem cells.

Nadri S, Soleimani M, Mobarra Z, Amini S

Researchers demonstrate that stem cells derived from human eye tissue can be converted into dopamine-producing neurons in a laboratory dish. This finding suggests these specific cells could potentially serve as a source for cell replacement therapies in neurodegenerative diseases like Parkinson's.

  • Stem cells from the conjunctiva of the eye were successfully isolated and cultured.
  • These cells differentiated into neurons expressing key dopamine-related genes and proteins.
  • The study proposes these cells as a viable source for future transplant therapies.
low2008-10-07 · Progress in neuro-psychopharmacology & biological psychiatry

mRNA expression of the Nurr1 and NGFI-B nuclear receptor families following acute and chronic administration of methamphetamine.

Akiyama K, Isao T, Ide S, Ishikawa M, Saito A

This rat study shows that methamphetamine exposure alters the expression of Nurr1 and NGFI-B genes in specific brain regions, with effects differing between acute and chronic drug use. These findings describe molecular changes in animal models of addiction rather than providing insights into NR4A2-related syndromes or potential treatments for children.

  • Methamphetamine increases Nurr1 mRNA in rat cortex and VTA within hours of administration.
  • Chronic meth use leads to persistent changes in Nurr1 and NGFI-B gene expression during withdrawal.
  • Acute meth challenge fails to further increase these genes in chronically exposed rats.
  • The study focuses on addiction mechanisms in rodents, not human genetic syndromes.
  • No clinical relevance or treatment implications for NR4A2-related conditions are identified.
low2008-10-01 · Development (Cambridge, England)

Anterior-posterior graded response to Otx2 controls proliferation and differentiation of dopaminergic progenitors in the ventral mesencephalon.

Omodei D, Acampora D, Mancuso P, Prakash N, Di Giovannantonio LG, Wurst W, Simeone A

This study identifies Otx2 as a critical regulator that controls the growth and maturation of dopamine-producing neuron precursors in the developing brain. The research demonstrates that precise levels of Otx2 are necessary to prevent premature differentiation and ensure proper proliferation of these cells.

  • Otx2 regulates the balance between progenitor cell division and maturation into dopamine neurons.
  • Lack of Otx2 causes precursors to stop dividing and differentiate too early.
  • Excess Otx2 increases the number of dopamine neuron precursors in a dose-dependent manner.
  • The study uses mouse mutants to establish these developmental mechanisms.
  • Findings suggest Otx2 could be a target for cell replacement therapies in Parkinson's disease.
low2008-10-01 · Synapse (New York, N.Y.)

Alterations in amphetamine-stimulated dopamine overflow due to the Nurr1-null heterozygous genotype and postweaning isolation.

Moore TM, Brown T, Cade M, Eells JB

A single missing copy of the Nurr1 gene causes subtle dopamine changes alone, but combined with early-life social isolation, it dramatically disrupts dopamine signaling in brain reward pathways. This interaction between genetics and environment suggests that developmental stressors can significantly worsen dopamine dysfunction in individuals with NR4A2 variants.

  • Isolation reduces dopamine overflow in healthy mice but increases it in Nurr1-mutant mice.
  • Nurr1 mutation alone causes only minor, often insignificant changes to basal dopamine levels.
  • The combination of genetic risk and environmental stress creates large differences in dopamine function.
  • This model links specific gene-environment interactions to potential behavioral disorders.
low2008-09-25 · PloS one

Analysis of area-specific expression patterns of RORbeta, ER81 and Nurr1 mRNAs in rat neocortex by double in situ hybridization and cortical box method.

Hirokawa J, Watakabe A, Ohsawa S, Yamamori T

This study maps the spatial distribution of Nurr1 mRNA in the rat neocortex to understand normal brain development. It confirms that Nurr1 expression is distinct from other layer-specific markers and correlates with cortical functional areas. The findings provide basic anatomical data on where this gene is active in a healthy rodent brain.

  • Nurr1 mRNA expression patterns are unique and mostly complementary to RORbeta and ER81 in rat cortex.
  • Nurr1 does not co-localize with ER81 at the single-cell level in layer 5 neurons.
  • Gene expression profiles correlate with the hierarchical processing order of cortical areas.
  • The study validates a new method for integrating gene expression data into 3D brain maps.
  • Results describe normal anatomy in rats, not disease mechanisms or treatments.
low2008-09-10 · The Journal of neuroscience : the official journal of the Society for Neuroscience

Identification of a novel nurr1-interacting protein.

Luo Y, Xing F, Guiliano R, Federoff HJ

Researchers identify a new protein, NuIP, that binds to Nurr1 and enhances its ability to activate genes critical for dopamine neuron function. Suppressing NuIP in cell models reduces cell division and lowers the expression of the dopamine transporter.

  • NuIP specifically interacts with the ligand-binding domain of Nurr1.
  • NuIP potentiates Nurr1-driven transcription from dopamine-related promoters.
  • NuIP and Nurr1 colocalize in adult midbrain dopaminergic neurons.
  • Silencing NuIP decreases cell division and dopamine transporter expression.
low2008-09-03 · Molecular and cellular endocrinology

FGF-8 stimulates the expression of NR4A orphan nuclear receptors in osteoblasts.

Lammi J, Aarnisalo P

This study shows that FGF-8 stimulates NR4A receptor expression in bone-forming cells, a process unrelated to the neurological symptoms of NR4A2 syndrome. The findings focus on osteoblast proliferation and differentiation pathways rather than dopaminergic neuron function or brain development.

  • FGF-8 induces NR4A receptors in osteoblasts via MAPK and PI-3K pathways.
  • NR4A receptors mediate the growth-promoting effects of FGF-8 in bone cells.
  • The study uses mouse cell lines, not human patients or neural tissue.
  • No connection to NR4A2-related neurodevelopmental disorders or Parkinsonism is established.
low2008-08-01 · The Journal of veterinary medical science

Effect of the co-administration of vitamin C and vitamin E on tyrosine hydroxylase and Nurr1 expression in the prenatal rat ventral mesencephalon.

Lee HY, Naha N, Ullah N, Jin GZ, Kong IK, Koh PO, Seong HH, Kim MO

This study shows that vitamins C and E increase the expression of Nurr1 and tyrosine hydroxylase in developing rat brain cells. The combination of these vitamins produces a stronger effect than either vitamin alone.

  • Vitamins C and E boost Nurr1 protein levels in prenatal rat brain tissue.
  • Vitamin C specifically increases tyrosine hydroxylase expression.
  • Combining vitamins C and E creates a synergistic increase in both proteins.
  • The study uses cultured rat cells, not human subjects or clinical trials.
low2008-07-10 · Neuroscience letters

Expression of the LRRK2 gene in the midbrain dopaminergic neurons of the substantia nigra.

Han BS, Iacovitti L, Katano T, Hattori N, Seol W, Kim KS

This study maps where the LRRK2 gene is active in the brain, finding it present in both dopamine-producing neurons and surrounding non-dopamine cells. It confirms that LRRK2 is highly expressed in the specific A9 dopamine neurons of the substantia nigra that are affected in Parkinson's disease.

  • LRRK2 exists in both dopamine neurons and nearby non-dopamine cells in the midbrain.
  • The gene shows strong expression specifically in A9 dopamine neurons of the substantia nigra.
  • Results suggest mutant LRRK2 may directly cause the selective death of these specific neurons.
low2008-06-11 · Proceedings of the National Academy of Sciences of the United States of America

Orphan nuclear receptor NR4A2 expressed in T cells from multiple sclerosis mediates production of inflammatory cytokines.

Doi Y, Oki S, Ozawa T, Hohjoh H, Miyake S, Yamamura T

This study identifies NR4A2 as a driver of inflammation in T cells within the context of multiple sclerosis, an autoimmune condition distinct from NR4A2-related syndromes. The research demonstrates that reducing NR4A2 levels lowers inflammatory cytokines and reduces disease severity in mouse models.

  • NR4A2 drives inflammatory cytokine production in T cells during multiple sclerosis.
  • Reducing NR4A2 via siRNA lowers IL-17 and IFN-gamma levels in mice.
  • Lower NR4A2 reduces the ability of T cells to transfer disease in animal models.
  • Findings focus on autoimmune mechanisms, not dopaminergic neuron development or function.
low2008-06-05 · Neurochemistry international

Expression of functional dopaminergic phenotype in purified cultured Müller cells from vertebrate retina.

Kubrusly RC, Panizzutti R, Gardino PF, Stutz B, Reis RA, Ventura AL, de Mello MC, de Mello FG

Retinal glial cells (Müller cells) can produce and release dopamine when cultured, a process driven by the Nurr1 transcription factor. This finding demonstrates that non-neuronal glial cells possess intrinsic dopaminergic machinery independent of neuronal influence.

  • Purified Müller cells synthesize dopamine from L-DOPA in culture.
  • These cells express key enzymes and transporters for dopamine processing.
  • Nurr1 is present in these glial cells, supporting their dopaminergic role.
  • Dopamine release occurs via transporter-mediated mechanisms.
  • This biology is specific to retinal glia, not central nervous system neurons.
low2008-05-28 · Neuroreport

Nurr1 transcriptionally regulates the expression of alpha-synuclein.

Yang YX, Latchman DS

Reduced levels of the Nurr1 protein cause an increase in alpha-synuclein expression, a mechanism linked to Parkinson's disease. This finding establishes a direct molecular link between NR4A2 function and alpha-synuclein regulation.

  • Decreased Nurr1 transcriptionally increases alpha-synuclein expression.
  • This mechanism is observed in Parkinson's disease contexts.
  • The study uses cell-based models to demonstrate this regulation.
low2008-05-21 · Biochemical and biophysical research communications

Anabolic effects of PTH in cyclooxygenase-2 knockout osteoblasts in vitro.

Choudhary S, Huang H, Raisz L, Pilbeam C

This study shows that blocking a specific enzyme (COX-2) allows parathyroid hormone to stimulate bone growth in mouse cells, revealing a mechanism where natural prostaglandins normally inhibit this process. The research identifies NR4A2 as one of the genes activated by this pathway, but it does not test treatments for NR4A2-related syndromes or address neurological symptoms.

  • PTH stimulates bone growth in mouse cells only when COX-2 is blocked.
  • NR4A2 gene expression increases significantly under these specific experimental conditions.
  • The study uses mouse cell cultures, not human patients or clinical data.
  • Findings relate to bone biology, not the neurological aspects of NR4A2 syndrome.
low2008-05-16 · BMC genomics

Comparative analysis of transcriptional profiling of CD3+, CD4+ and CD8+ T cells identifies novel immune response players in T-cell activation.

Wang M, Windgassen D, Papoutsakis ET

This study maps gene activity in T-cells during immune activation and identifies NR4A2 as one of several genes involved in communication between different T-cell subsets. It provides no information on NR4A2's role in the brain, neurodevelopment, or potential treatments for NR4A2-related syndromes.

  • NR4A2 appears only as an incidental marker in this immunology study.
  • The research focuses on T-cell activation, not neurological function.
  • No clinical data, patient phenotypes, or treatment insights are provided.
  • Findings do not translate to understanding NR4A2-related neurodevelopmental disorders.
low2008-05-03 · Journal of neurochemistry

Extracellular signal-regulated kinases (ERK) and protein kinase C (PKC) activities are involved in the modulation of Nur77 and Nor-1 expression by dopaminergic drugs.

Bourhis E, Maheux J, Rouillard C, Lévesque D

Dopamine-acting drugs change Nur77 and Nor-1 gene activity through specific cellular signaling pathways involving MEK and PKC enzymes. These findings map the molecular mechanisms by which dopamine drugs influence these receptors, but they do not provide direct evidence for treating NR4A2-related syndromes in humans.

  • Dopamine drugs modulate Nur77 and Nor-1 via MEK and PKC signaling pathways.
  • Nur77 and Nor-1 respond differently to dopamine agonists versus antagonists.
  • This is preclinical research using animal models, not human clinical data.
  • The study focuses on basic molecular biology rather than therapeutic outcomes.
low2008-04-25 · Neuroscience

Preliminary evidence for a modulation of fetal dopaminergic development by maternal immune activation during pregnancy.

Meyer U, Engler A, Weber L, Schedlowski M, Feldon J

Maternal immune activation in pregnant mice increases the number of dopamine-producing neurons in the fetal brain and alters key developmental genes. This suggests that prenatal infection can directly modify early brain development pathways relevant to neurotransmitter systems.

  • Mouse study shows maternal immune challenge boosts fetal dopamine neuron counts.
  • Prenatal inflammation changes expression of Nurr1, Pitx3, Shh, and Fgf8 genes.
  • Findings link maternal infection to altered dopaminergic system development in fetuses.
low2008-04-24 · Stem cells (Dayton, Ohio)

Alpha-chemokines regulate proliferation, neurogenesis, and dopaminergic differentiation of ventral midbrain precursors and neurospheres.

Edman LC, Mira H, Erices A, Malmersjö S, Andersson E, Uhlén P, Arenas E

Alpha-chemokines increase the number of functional dopamine-producing neurons in rat brain cell cultures. These findings suggest potential applications for developing cell therapies for Parkinson's disease.

  • CXCL6 promotes differentiation of Nurr1+ precursors into dopamine neurons in vitro.
  • CXCL8 enhances progenitor division and increases dopamine neuron numbers in rodent cells.
  • Treated neurons are functional, showing calcium fluxes in response to stimulation.
  • Study uses rat ventral midbrain cultures, not human patients or NR4A2 variants.
low2008-04-18 · FASEB journal : official publication of the Federation of American Societies for Experimental Biology

CREB has a context-dependent role in activity-regulated transcription and maintains neuronal cholesterol homeostasis.

Lemberger T, Parkitna JR, Chai M, Schütz G, Engblom D

This study uses mouse models to show that CREB and CREM proteins regulate the Nr4a2 gene in specific brain regions depending on the stimulus, such as seizures or drug exposure. It also finds that losing these proteins disrupts cholesterol metabolism in the brain.

  • CREB and CREM selectively control Nr4a2 expression in mouse hippocampus and striatum.
  • CREM can compensate for missing CREB in regulating activity-induced gene transcription.
  • Loss of CREB/CREM disrupts cholesterol synthesis and accumulation in mouse brains.
low2008-04-10 · The Journal of comparative neurology

Sall3 is required for the terminal maturation of olfactory glomerular interneurons.

Harrison SJ, Parrish M, Monaghan AP

Sall3 is essential for the final development of specific neurons in the olfactory bulb's glomerular layer, which are critical for processing smell. Without Sall3, these neurons fail to mature properly, leading to reduced numbers and loss of key neurotransmitters, though early neuron formation appears normal.

  • Sall3 is needed for final maturation of olfactory glomerular neurons
  • Loss of Sall3 reduces interneuron numbers in the olfactory bulb
  • Neurotransmitters like dopamine and GABA are disrupted
  • Early neuron development and migration remain intact
  • Sall3 deficiency causes loss of tyrosine hydroxylase in olfactory bulb
low2008-04-03 · Stem cells (Dayton, Ohio)

Embryonic stem cell-derived Pitx3-enhanced green fluorescent protein midbrain dopamine neurons survive enrichment by fluorescence-activated cell sorting and function in an animal model of Parkinson's disease.

Hedlund E, Pruszak J, Lardaro T, Ludwig W, Viñuela A, Kim KS, Isacson O

Researchers successfully purified midbrain dopamine neurons from mouse embryonic stem cells and transplanted them into rats with Parkinson's disease, where the grafts survived and restored motor function. This study demonstrates that enriched dopaminergic neuron populations can effectively integrate and function in an animal model of neurodegeneration. The work provides proof-of-concept for cell purification strategies but does not involve human patients or NR4A2-specific genetics.

  • Purified mouse stem-cell-derived dopamine neurons survived transplantation in Parkinson's rats.
  • Enriched grafts restored motor function and innervated the host striatum.
  • Study uses animal models, not human clinical data or NR4A2 variants.
  • Demonstrates feasibility of cell sorting for potential future cell therapies.